Leaflet DEFERASIROX ALVOGEN 90mg film-coated tablets

Product code:
W67447001
Quantity:
30
Indicated for:
iron overload
Route of administration:
oral
Substance:
deferasirox (chelating agent)
ATC
V03AC03 — Various | All other therapeutic products | All other therapeutic products | Iron chelating agents
Deferasirox is an iron chelator used for the treatment of chronic iron overload in patients with frequent blood transfusions, such as those with major thalassemia. It works by binding excess iron, facilitating its elimination through feces.

The medication is taken orally, usually once daily, with the dose adjusted based on the body's iron levels and the patient's weight. Common side effects include nausea, diarrhea, abdominal pain, and elevated liver enzymes.

Deferasirox is contraindicated in patients with severe renal impairment, hepatic failure, or hypersensitivity to the active substance. Its use also requires regular monitoring of renal and hepatic function.

This medication is an effective option for managing iron overload, helping to prevent complications associated with this condition.

General data about DEFERASIROX ALVOGEN 90mg

Substance:
deferasirox
Date of latest medicines list:
01-04-2021
Product code:
W67447001
Concentration:
90mg
Pharmaceutical form:
film-coated tablets
Quantity:
30
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
SYNTHON HISPANIA, S.L. - SPANIA
Holder:
ALVOGEN PHARMA TRADING EUROPE EOOD - BULGARIA
Number:
13374/2020/01
Shelf life:
2 years

Pharmaceutical forms available for deferasirox

Concentrations available for deferasirox

  • 125mg
  • 180mg
  • 250mg
  • 360mg
  • 500mg
  • 90mg